4//SEC Filing
Jayasuriya Anula 4
Accession 0001493152-24-000154
CIK 0000876343other
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 7:08 PM ET
Size
5.4 KB
Accession
0001493152-24-000154
Insider Transaction Report
Form 4
Jayasuriya Anula
Director
Transactions
- Purchase
Common Shares, no par value
2023-12-29$1.09/sh+10,000$10,900→ 10,000 total
Footnotes (2)
- [F1]The price reported is a weighted average. The shares were purchased in multiple transactions at prices ranging from not less than $1.08 to not more than $1.09. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.
- [F2]Does not include common shares that may be acquired upon the exercise of stock options outstanding as of the date of this report.
Documents
Issuer
Lineage Cell Therapeutics, Inc.
CIK 0000876343
Entity typeother
Related Parties
1- filerCIK 0001822933
Filing Metadata
- Form type
- 4
- Filed
- Jan 1, 7:00 PM ET
- Accepted
- Jan 2, 7:08 PM ET
- Size
- 5.4 KB